JMP Securities Sticks to Its Hold Rating for The RMR Group (RMR)
JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s shares closed ...
JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.